<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6676">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02080403</url>
  </required_header>
  <id_info>
    <org_study_id>CLI/016P</org_study_id>
    <nct_id>NCT02080403</nct_id>
  </id_info>
  <brief_title>The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis</brief_title>
  <official_title>Multi-Center Phase 3 Trial of Chlorhexidine Gluconate Chip for the Use in Subjects With Peri-Implantitis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dexcel Pharma Technologies Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dexcel Pharma Technologies Ltd.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Institutional Review Board</authority>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <authority>United Kingdom: National Health Service</authority>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to assess the efficacy and safety of PerioChip® (Chlorhexidine
      gluconate chip) in the treatment of patients with Peri-implantitis.

      The hypothesis of the study is that PerioChip® in adjunct to mechanical subgingival
      debridement is more effective in the treatment of peri-implantitis when compared to the
      common method of mechanical subgingival debridement alone. The primary efficacy measure will
      be the reduction in probing pocket depth at 6 months as measured at sites of qualifying
      target implant.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Absolute change in mean probing Pocket Depth for selected target implants</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Absolute change in mean probing Pocket Depth of selected target implants in patients with baseline Pocket Depth measurement of 6-8 mm inclusive</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in percentage of selected target implants Bleeding on Probing</measure>
    <time_frame>Baseline to 4 and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absolute change in mean probing Pocket Depth of selected target implants</measure>
    <time_frame>Baseline to 4 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Peri-Implantitis</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment, 2.5 mg Chlorhexidine Gluconate chip (PerioChip®) inserted every two weeks starting at Baseline for the first 3 months, plus mechanical Subgingival Debridement at Baseline and 3 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Mechanical Subgingival Debridement at Baseline and 3 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2.5 mg Chlorhexidine gluconate chip</intervention_name>
    <description>Subgingival debridement will be carried out for each one of the target implant. Upon completion of the debridement a PerioChip® will be inserted in each one of the target implant.</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>PerioChip®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Good general health

          -  At least one implant in the oral cavity with clinical and radiographical signs of
             peri-implantitis. Including bone loss in combination with bleeding and/or suppuration
             on probing and a peri-implant Probing Depth (PD) of 5-8 mm.

          -  The implants have been in function for more than 2 years.

          -  Fixed prosthetic restoration of the implant.

        Exclusion Criteria:

          -  Pregnancy.

          -  Patient uses Chlorhexidine oral rinses/ mouthwashes on a regular basis.

          -  Allergic reaction to Chlorhexidine.

          -  Active Periodontitis which required definitive treatment.

          -  Presence of orthodontic appliances, or any removable appliances, that impinges on
             the tissues being assessed.

          -  Use of systemic antibiotic therapy and/or chronically use of non-steroidal
             anti-inflammatory drugs (NSAIDs).

          -  Uncontrolled diabetes, of any type.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eli Machtei, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Center Haifa, Israel, 9602</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sigalit Melcer</last_name>
    <email>sigalit.melcer@dexcel.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Center</name>
      <address>
        <city>Haifa</city>
        <zip>9602</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Eli Machtei, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 4, 2014</lastchanged_date>
  <firstreceived_date>March 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peri-Implantitis</keyword>
  <keyword>Periodontal Diseases</keyword>
  <keyword>Chlorhexidine gluconate</keyword>
  <keyword>PerioChip</keyword>
  <keyword>Anti-Infective Agents</keyword>
  <keyword>Mouth Diseases</keyword>
  <keyword>Antiseptics</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
